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CORRESPONDENCE
Electrical Impedance Tomography for Positive
End-Expiratory Pressure Titration in COVID-19–related
Acute Respiratory Distress Syndrome
To the Editor:
Coronavirus disease (COVID-19) spreads rapidly and has already
resulted in severe burden to hospitals and ICUs worldwide. Early
reports described progression to acute respiratory distress syndrome
(ARDS) in 29% of cases (1).
It is unknown how to titrate positive end-expiratory pressure
(PEEP) in patients with ARDS. Patient survival improved if higher
PEEP successfully recruited atelectatic lung tissue (2). However,
excessive PEEP caused alveolar overdistention, resulting in reduced
patient survival (3). Therefore, PEEP should be personalized to
maximize alveolar recruitment and minimize the amount of
alveolar overdistention. Electrical impedance tomography (EIT)
provides a reliable bedside approach to detect both alveolar
overdistention and alveolar collapse (4).
We describe a case series of patients with COVID-19 and
moderate to severe ARDS in whom EIT was applied to personalize
PEEP based on the lowest relative alveolar overdistention and
collapse. Subsequently, we compared this PEEP level with the PEEP
that could have been set according to the lower or higher PEEP–FIO2
table from the ALVEOLI trial (5). These early experiences may help
clinicians to titrate PEEP in patients with COVID-19 and ARDS.
Methods
Study design and inclusion criteria. We conducted this case series
between March 1, 2020, and March 31, 2020, in our tertiary referral
ICU (Erasmus Medical Center, Rotterdam, the Netherlands).
All consecutive mechanically ventilated patients admitted to the
ICU with COVID-19 and moderate to severe ARDS (according
to the Berlin definition of ARDS) were included in this study.
COVID-19 was defined as a positive result on a PCR of sputum,
nasal swab, or pharyngeal swab specimen. The local medical ethical
committee approved this study. Informed consent was obtained
from all patients’ legal representatives.
Study protocol. A PEEP trial was performed daily in all patients
according to our local mechanical ventilation protocol. Patients were
fully sedated with continuous intravenous infusion of propofol,
midazolam, and opiates. Persisting spontaneous breathing efforts
were prevented with increased sedation or neuromuscular blockade.
Arterial blood pressure was measured continuously. Noradrenalin
was titrated to maintain a mean arterial blood pressure above
65 mm Hg at the start of the PEEP trial.
All patients were ventilated in pressure-control mode. FIO2 was
titrated to obtain a peripheral oxygen saturation between 92% and
95%. The other mechanical ventilation parameters (i.e., PEEP
driving pressure, respiratory rate, and inspiratory/expiratory ratio)
remained unchanged. Plateau airway pressure and total PEEP
were measured during a zero-flow state with an inspiratory and
expiratory hold procedure, respectively. Absolute transpulmonary
pressures were measured with an esophageal balloon catheter
(CooperSurgical or NutriVent). The position and balloon inflation
status were tested with chest compression during an expiratory
hold maneuver.
We monitored bedside ventilation distribution with EIT
(Pulmovista 500; Dräger or Enlight 1800; Timpel). An EIT belt
was placed around the patient’s thorax in the transversal plane
corresponding with the fourth to fifth intercostal parasternal space. The
belt was placed daily (Pulmovista) or once in 3 days (Enlight), according
to manufacturer’s instructions. EIT data were visualized on screen
during the entire study protocol without repositioning the EIT belt.
Subsequently, we performed a decremental PEEP trial. The
PEEP was increased stepwise until the PEEP was 10 cm H2O above
the baseline PEEP with a minimum PEEP of 24 cm H2O
(PEEPhigh), corresponding with the maximum PEEP advised by the
PEEP–FIO2 table. The PEEP trial was limited to a lower PEEP level
in case of hypotension (mean arterial blood pressure ,60 mm Hg)
or desaturation (peripheral oxygen saturation ,88%). PEEPhigh
was maintained for at least 1 minute. From PEEPhigh, the PEEP was
reduced in 2–cm H2O steps of 30 seconds until the EIT showed
evident collapse. The PEEP was reduced an additional 2 cm H2O to
confirm a further increase in collapse. The EIT devices provided
percentages of relative alveolar overdistention and collapse at every
PEEP step. Lastly, the total PEEP was set (PEEPset) at the PEEP
level above the intersection of the curves representing relative
alveolar overdistention and collapse (Figure 1) (6).
Baseline characteristics and laboratory analyses were retrieved
from the patient information system. Diffuse or focal ARDS was
established with chest X-ray or lung computed tomography (CT)
scan, similar to the LIVE (Lung Imaging for Ventilatory Setting
in ARDS) study (7).
Statistical analysis. Data were presented as medians and
interquartile ranges (IQRs). Only PEEPset, as determined by the first
PEEP trial, of each patient was used for analyses. The absolute
distance in cm H2O between PEEPset and the closest PEEP level
that could have been set based on the lower PEEP–FIO2 table or the
higher PEEP–FIO2 table from the ALVEOLI trial was calculated (5).
The Wilcoxon signed-rank test was used to test the difference
between PEEPset and the absolute distance to either the PEEP–FIO2
table and to test the difference in PEEPset between the first and last
PEEP trial (up to Day 7). Correlations were assessed using
Spearman’s rank correlation coefficient (r).
Results
Study population. We included 15 patients with COVID-19–related
ARDS (Table 1). Patients had a body mass index (BMI) of
30 kg/m2 (IQR, 27–34 cm H2O). All patients had high concentrations
of C-reactive protein and required vasopressors during the first
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week after ICU admission. In addition, 14 (93%) patients had or
progressed to diffuse ARDS on their chest X-ray or lung CT scan.
PEEPset in COVID-19–related ARDS. We conducted a total of
63 PEEP trials, of which 52 were performed in the supine position.
The median amount of PEEP trials per patient was 3 (IQR, 2–4.5).
PEEPset based on EIT was 21 cm H2O (IQR, 16–22 cm H2O).
Driving pressure was below 13 cm H2O in all patients (Table 1). In
one PEEP trial (1.6%), we did not reach a PEEPhigh of 10 cm H2O
above the baseline PEEP because of hemodynamic instability
(mean arterial blood pressure ,60 mm Hg). No pneumothoraxes
were observed. At 28 days, four patients died (26.7%), three
patients were weaning from mechanical ventilation (20.0%),
and eight patients were discharged from the ICU (53.3%).
PEEPset was 2 cm H2O (IQR, 0–5 cm H2O) above the PEEP set
by the higher PEEP–FIO2 table and 10 cm H2O (IQR, 7–14 cm
H2O) above the PEEP set by the lower PEEP–FIO2 table (P=0.01 for
the absolute difference) (Figure 2A). There was no correlation between
PEEPset and FIO2 (r=0.11; P = 0.69). However, we did find a significant
correlation between PEEPset and BMI (r=0.76; P=0.001) (Figure 2B).
PEEPset did not change significantly over time (Figure 2C).
Discussion
In 15 patients with COVID-19–related ARDS, personalized PEEP at
the level of lowest relative alveolar overdistention and collapse, as
measured with EIT, resulted in high PEEP. These PEEP levels did
not result in high driving pressure or transpulmonary pressure. In
addition, PEEP trials did not result in relevant hemodynamic
instability or pneumothorax. PEEPset corresponded better with the
higher PEEP–FIO2 table than the lower PEEP–FIO2 table and was
positively correlated with BMI.
In COVID-19–related ARDS, both a low lung recruitability
(L-type) and a high lung recruitability phenotype (H-type) have been
described based on lung compliance and the amount of nonaerated
lung tissue on lung CT scans (8). Especially in patients with the
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A: 29 cmH2O B: 21 cmH2O C: 15 cmH2O D: 9 cmH2O
Figure 1. Total set positive end-expiratory pressure (PEEP) based on electrical impedance tomography. (A) Ventilation distribution at four levels of PEEP.
The top row shows the ventilation distribution in blue, whereas the bottom row shows relative alveolar overdistention in orange and relative alveolar
collapse in white. The percentages of relative alveolar overdistention and collapse are presented as well. At a total PEEP of 29 cm H2O, the dorsal
areas of the lung are mainly ventilated, whereas the ventral parts are not ventilated because of overdistention. At a total PEEP of 9 cm H2O, the
ventral parts are mainly ventilated (with more ventilation in the right lung than the left lung), and the dorsal parts are not ventilated because of alveolar
collapse. At a total PEEP between 15 and 21 cm H2O, ventilation is mainly distributed to the center. (B) Relative alveolar overdistention, collapse,
and dynamic compliance. Relative alveolar overdistention and collapse and the dynamic compliance of the respiratory system are shown during
a decremental PEEP trial. At 29 cm H2O PEEP, there is relative alveolar overdistention but no relative collapse, whereas at 9 cm H2O PEEP, there is relative
alveolar collapse but no relative overdistention. The total PEEP was set at the PEEP level above the intersection of the curves representing relative alveolar
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L-type, low PEEP was advised because higher PEEP would only
result in alveolar overdistention without the benefit of alveolar
recruitment. In 12 patients with COVID-19–related ARDS, Pan
and colleagues (9) used the recruitment-to-inflation ratio and
found that lung recruitability was low as well. However, in our first
15 patients with COVID-19–related ARDS, personalized PEEP at
the level of lowest relative alveolar overdistention and collapse, as
measured with EIT, resulted in high PEEP. Perhaps we included
only patients with the H-type, but it is more likely that both
phenotypes are the extremes of a recruitability continuum. The
recruitability continuum represents the amount of nonaerated lung
tissue resulting from edema. Gattinoni and colleagues (8) already
described that one patient with COVID-19–related ARDS could
progress from the L-type to the H-type as the amount of
nonaerated lung tissue increased. If these results can be generalized,
most patients with COVID-19 will become recruitable to some
extent. The potential changes in recruitability over time make a
personalized PEEP titration approach very interesting, although we
did not observe a significant change in PEEPset over time.
In addition, a secondary analysis of the ALVEOLI trial found that
higher PEEP improved survival in patients with a hyperinflammatory
ARDS phenotype (10). The hyperinflammatory phenotype could be
predicted accurately using IL-6, tumor necrosis factor receptor, and
vasopressors. Given the very high C-reactive protein concentrations
and the use of vasopressors in all our patients, we assumed that the
majority of patients in our study were in a hyperinflammatory state.
The LIVE trial predicted PEEP response based on lung
morphology and found that patients with focal ARDS benefited
from lower PEEP and that patients with diffuse ARDS benefited
from higher PEEP (7). In our study, the majority of patients had or
progressed to diffuse ARDS, based on chest X-ray or lung CT scan.
As a consequence, these patients with COVID-19 were likely to
respond to higher PEEP.
We realize that the availability of EIT is limited in ICUsworldwide.
In clinical practice, the PEEP–FIO2 table is often used because it is a
simple approach to titrate PEEP. This study showed that PEEPset at
the level of lowest relative alveolar overdistention and collapse, as
measured with EIT, corresponded better with the higher PEEP–FIO2
table in 15 patients with COVID-19–related ARDS. However,
the patients in our study had a high BMI, resulting in a lower
transpulmonary pressure and increased PEEP requirement. Higher
PEEP should be used with caution in patients with focal ARDS or low
BMI. Moreover, response to higher PEEP should always be monitored
in terms of driving pressure (2) or oxygenation (11). n
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Figure 2. (A) Total set positive end-expiratory pressure (PEEPset) versus higher and lower PEEP–FIO2 tables. The solid and dashed lines represent the
PEEP–FIO2 combination to be used according to the lower and higher PEEP–FIO2 tables from the ALVEOLI trial. Each marker represents PEEPset at the
level of lowest relative alveolar overdistention and collapse as measured with electrical impedance tomography. Only the first PEEP trial of each patient is
presented. The crosses indicate subjects who died within 28 days following ICU admission. There was no correlation between PEEPset and FIO2 (r=0.11;
P=0.69). (B) PEEPset versus body mass index (BMI). The correlation between BMI and PEEPset after the first PEEP trial for each patient is shown.
Spearman’s rank correlation coefficient r=0.76 with P=0.001. Similar markers in Figures 2A and 2B represent the same patient. (C) Change in PEEP
compared with the first PEEP trial. The change in PEEPset compared with the first PEEP trial is represented by the median (orange lines), interquartile
ranges (boxes), and minimum and maximum values (whiskers). PEEPset did not change significantly over time. The number between parentheses
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Bronchoscopy in Patients with COVID-19 with Invasive
Mechanical Ventilation: A Single-Center Experience
To the Editor:
Severe coronavirus disease (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads
to acute respiratory distress syndrome and hypoxemic respiratory
failure (1).
The University Hospital de la Santa Creu i Sant Pau serves an
area of downtown Barcelona, Spain, of about 420,000 citizens. The
first case of COVID-19 at our hospital was detected on March 17,
2020. The first two cases in the ICU were detected on March 13, and
the number of beds dedicated to intensive care multiplied by four,
with 163 new ICU admissions and 139 patients requiring
mechanical ventilation between March 13 and April 4. During this
period, 59 patients were discharged, 23 died, and 81 were still in the
ICU.
BAL, bronchial wash, and protected specimen brush are
bronchoscopic procedures used to provide microbiological samples
from lower respiratory airways. However, because of the risk of viral
transmission, bronchoscopy is not routinely indicated for the
diagnosis of COVID-19 (2).
Bronchoscopy in critically ill patients with COVID-19 has been
required to manage complications (atelectasis, hemoptysis, etc.) as
well as to obtain samples for microbiological cultures and to assist
in the management of artificial airways (guide intubation and
percutaneous tracheostomy) (3).
Because no series of intubated patients with COVID-19
submitted to bronchoscopy has been published so far,
we describe our experience in performing flexible
bronchoscopies in patients with COVID-19 with
severe acute hypoxemic respiratory failure requiring invasive
mechanical ventilation during the first 3 weeks of the epidemic
outbreak.
Between March 16 and April 4, 2020, a total of 101
bronchoscopies were performed in 93 patients with COVID-19.
Eight patients required two bronchoscopies.
Indications for bronchoscopy were as follows: radiological
and/or clinical deterioration suggesting possible superinfection
(63/101) as well as airway secretion management with/without
atelectasis (38/101). Intensivists indicated procedures 6.6 days
(range, 1–17) after intubation. At the time of indication, the
median FIO2 was 0.8 (interquartile range [IQR], 0.67–0.82),
the median positive end-expiratory pressure was 10 cm H2O
(IQR, 9–11), and the median PaO2/FIO2 ratio was 111 (IQR,
103–125).
Procedures were performed in either supine (74/101) or prone
(27/101) position, under usual intravenous sedation and with
pressure-controlled ventilation mode. Disposable scopes were used
in all cases (Ambu aScope 4 Broncho, Large 5.8/2.8. Ambu A/S),
and minimal staff attended the procedure bedside (one expert
bronchoscopist occasionally accompanied by a staff intensivist).
One out of two bronchoscopists got infected with SARS-CoV-2 and
developed COVID-19. As a consequence, our colleague had to be
replaced by another bronchoscopist during the third week.
Before the procedure, all the necessary equipment and
materials were prepared outside the patient room, including saline,
syringes, mucoactive drugs, microbiological recipients, connections,
and bronchoscopy system (scope and screen). A negative-pressure
room was not always available for the procedures owing to the
variety of locations adapted for intensive care support. As
recommended (2), level III of personal protective equipment was
used, including N95 or FPP3 mask, goggles, double gloves, and a
plastic protective gown including head and neck cover.
Bronchoscopic examination included orotracheal tube
positioning check, direct inspection of tracheal and bronchial
mucosa, suctioning of secretions, and mucoactive agent instillation
if necessary (hypertonic saline combined with hyaluronic acid), and
in 63 cases, a mini-BAL with 60-ml saline aliquots at room
temperature was performed just before the end of procedure
for microbiological sampling. The bronchial segment to
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